Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKCA | IBRX | NMRA | ||
| Company | Akcea Therapeutics Inc | Immunitybio Inc | Neumora Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.15 | 2.69 | 11.26 | ||
| High | 18.17 | 2.86 | 11.57 | ||
| Low | 18.13 | 2.63 | 10.97 | ||
| Last | 18.17 | 2.78 | 11.33 | ||
| Change | +0.03 | +0.09 | -0.01 | ||
| % Change | +0.17% | +3.35% | -0.09% | ||
| Volume | 815,300 | 8,047,100 | 936,400 | ||
| 20-Day Average Volume | 661,490 | 6,482,755 | 906,890 | ||
| Previous Close | 18.14 | 2.69 | 11.34 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.14 | 3.60 | 10.45 | ||
| 20-Day Raw Stochastic | 70.59% | 10.53% | 89.07% | ||
| 20-Day Relative Strength | 73.10% | 35.84% | 52.66% | ||
| Weighted Alpha | -23.90 | -57.45 | -19.37 | ||
| Today's Opinion | 72% Buy | 88% Sell | 56% Sell | ||
| Previous Opinion | 64% Buy | 88% Sell | 64% Sell | ||
| Last Month's Opinion | 8% Buy | 24% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.22% since 10/02/20 | +4.12% since 12/19/24 | +7.90% since 12/19/24 | ||
| Low | 18.08 on 10/05/20 | 2.50 on 12/23/24 | 10.07 on 12/20/24 | ||
| High | 18.17 on 10/09/20 | 2.86 on 12/27/24 | 11.57 on 12/27/24 | ||
| 1-Month | |||||
| %Chg | +0.17% since 09/09/20 | -45.49% since 11/27/24 | +16.09% since 11/27/24 | ||
| Low | 18.05 on 09/21/20 | 2.50 on 12/23/24 | 9.38 on 12/04/24 | ||
| High | 18.22 on 09/28/20 | 5.16 on 11/29/24 | 11.57 on 12/27/24 | ||
| 3-Month | |||||
| %Chg | +36.72% since 07/09/20 | -29.26% since 09/27/24 | -12.31% since 09/27/24 | ||
| Low | 9.81 on 08/05/20 | 2.50 on 12/23/24 | 9.34 on 11/19/24 | ||
| High | 19.65 on 08/31/20 | 7.48 on 10/25/24 | 17.19 on 10/18/24 | ||
| 6-Month | |||||
| %Chg | +11.88% since 04/09/20 | -57.49% since 06/27/24 | +23.15% since 06/27/24 | ||
| Low | 9.81 on 08/05/20 | 2.50 on 12/23/24 | 9.14 on 06/28/24 | ||
| High | 19.65 on 08/31/20 | 7.48 on 10/25/24 | 17.19 on 10/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,846,054 | 1,874,476 | 1,832,102 | ||
| Shares Outstanding, K | 101,599 | 696,831 | 161,561 | ||
| Annual Sales | 488,540,000 | 620,000 | 0 | ||
| Annual Net Income | 40,770,000 | -583,200,000 | -235,930,000 | ||
| Last Quarter Sales | 22,380,000 | 6,110,000 | 0 | ||
| Last Quarter Net Income | -49,580,000 | -85,730,000 | -72,550,000 | ||
| 60-Month Beta | 1.45 | 0.86 | 3.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 08/04/20 | -0.14 on 11/12/24 | -0.45 on 11/12/24 | ||
| Latest Earnings Date | 11/03/20 | 11/13/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||